While debate rages on about when the Federal Reserve might start cutting interest rates, biotech industry analysts are making the case that the argument for stocks in the sector is …
The health-care sector may have done poorly in the last couple of years, but analysts are bullish on it right now . “Just two weeks into 2024, the healthcare sector …
[needs a top section] Bank of America has named four small and medium-sized pharmaceutical stocks as its “top picks” for 2024, highlighting their strong potential for regulatory approvals and product …